Trial Profile
A Randomised, Double-blind, Double-dummy, Placebo Controlled (With Rescue Medication), Multicenter Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 05 Sep 2012 Results presented at the 22nd Annual Congress of the European Respiratory Society.
- 27 Mar 2012 Planned number of patients changed from 330 to 343 as reported by European Clinical Trials Database.
- 03 Feb 2012 Actual patient number (350) added as reported by ClinicalTrials.gov.